Joe Wiley, Amryt Pharma CEO
#JPM23 kicks off with an acquisition as Chiesi inks all-cash $1B+ deal for Amryt
As many of the industry’s bigwigs arrive in the Bay Area to hash out deals, Chiesi Farmaceutici is showing up with an all-cash acquisition in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
